Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
National Jewish Health · University of Colorado Denver · +34 more institutions
Abstract
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium xenopi among the slowly growing NTM and Mycobacterium abscessus among the rapidly growing NTM. A panel of experts was carefully selected by leading international respiratory medicine and infectious diseases societies (ATS, ERS, ESCMID, IDSA) and included specialists in pulmonary medicine,…
Citation impact
- FWCI
- 67.27
- Percentile
- 100%
- References
- 228
Authors
21- CLCharles L. DaleyCorresponding
National Jewish Health, University of Colorado Denver
- JMJonathan M. Iaccarino
Boston University
- CLChristoph Lange
Karolinska Institutet, German Center for Infection Research, Research Center Borstel - Leibniz Lung Center, University of Lübeck
- ECEmmanuelle Cambau
Inserm, Délégation Paris 7, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière
- RJRichard J. Wallace
The University of Texas Health Science Center at Tyler
Topics & keywords
- Medicine
- Mycobacterium abscessus
- Mycobacterium kansasii
- Nontuberculous mycobacteria
- Guideline
- Intensive care medicine
- Infectious disease (medical specialty)
- Disease